Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07908875Phase 3Not yet recruiting
A Phase 3 trial of hybutimibe in ischemic stroke, Transient Ischemic Attack (TIA), sponsored by Yejishan Hospital of Wannan Medical College. Planned start Nov 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07908875.